MoonLake Immunotherapeutics Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 4 | -$0.28 | -$0.28 | -$0.28 |
| Q2 2024 | 2 | -$0.44 | -$0.44 | -$0.44 |
| Q3 2024 | 7 | -$0.73 | -$0.43 | -$0.60 |
| Q1 2025 | 3 | -$0.71 | -$0.53 | -$0.62 |
| Q2 2025 | 2 | -$0.66 | -$0.66 | -$0.66 |
| Q3 2025 | 2 | -$0.70 | -$0.70 | -$0.70 |
| Q4 2025 | 2 | -$0.67 | -$0.67 | -$0.67 |
MoonLake Immunotherapeutics Earnings Date And Information
MoonLake Immunotherapeutics last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.56 earnings per share for the quarter, missing analysts' consensus estimates of $-0.44 by $0.12. The company had revenue of 0 for the quarter and had revenue of 0 for the year. MoonLake Immunotherapeutics has generated $-1 earnings per share over the last year ($-0.73 diluted earnings per share) and currently has a price-to-earnings ratio of -41.89. MoonLake Immunotherapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based on prior year's report dates.
MoonLake Immunotherapeutics Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.44 | -$0.57 | -0.13 | $0 | $0 |
| 08/07/2024 | Q2 2024 | -$0.28 | -$0.39 | -0.11 | $0 | $0 |
| 05/07/2024 | Q1 2024 | -$0.21 | -$0.22 | -0.01 | $0 | |
| 05/07/2024 | Q4 2023 | -$0.21 | -$0.12 | 0.09 | $19,738 | |
| 09/29/2023 | Q3 2023 | -$0.18 | $0 | |||
| 08/10/2023 | Q2 2023 | -$0.25 | -$0.23 | 0.02 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.31 | $0 | |||
| 03/20/2023 | Q4 2022 | -$0.32 | -$0.42 | -0.1 | $0 | |
| 11/14/2022 | Q3 2022 | -$0.32 | -$0.40 | -0.08 | $0 | |
| 08/12/2022 | Q2 2022 | -$0.54 | -$0.49 | 0.05 | $0 | |
| 05/16/2022 | Q1 2022 | -$0.43 | $0 | |||
| 02/17/2022 | Q4 2021 | -$0.15 | $0 | |||
| 11/12/2021 | Q3 2021 | -$0.17 | $0 | |||
| 08/16/2021 | Q2 2021 | -$0.89 | $0 | |||
| 05/21/2021 | Q1 2021 | -$0.01 | $0 |
MoonLake Immunotherapeutics Earnings: Frequently Asked Questions
-
When is MoonLake Immunotherapeutics's earnings date?
MoonLake Immunotherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based off last year's report dates.
-
How can I listen to MoonLake Immunotherapeutics's earnings conference call?
The conference call for MoonLake Immunotherapeutics's latest earnings report can be listened to online.
-
How can I read MoonLake Immunotherapeutics's conference call transcript?
The conference call transcript for MoonLake Immunotherapeutics's latest earnings report can be read online.
-
How much profit does MoonLake Immunotherapeutics generate each year?
MoonLake Immunotherapeutics (:MLTX) has a recorded net income of $0. MoonLake Immunotherapeutics has generated $-0.73 earnings per share over the last four quarters.
-
What is MoonLake Immunotherapeutics's price-to-earnings ratio?
MoonLake Immunotherapeutics (:MLTX) has a price-to-earnings ratio of -41.89 and price/earnings-to-growth ratio is 0.98.
